Anne Crotteau | executive |
Eric Dube | executive |
Jula Inrig | executive |
Peter Heerma | executive |
Chris Cline | executive |
Anupam Rama | analyst |
Tyler Van Buren | analyst |
Joseph Schwartz | analyst |
Carter L. Gould | analyst |
Jason Zemansky | analyst |
Maurice Raycroft | analyst |
Lachlan Hanbury-Brown | analyst |
Yigal Nochomovitz | analyst |
William Reid Mcculloch | analyst |
Vamil Divan | analyst |
Alexander Thompson | analyst |
Laura Chico | analyst |
Antonio Arce | analyst |
Allison Bratzel | analyst |
Good day, and welcome to the Travere Therapeutics First Quarter 2024 Financial Results and Corporate Update Conference Call. Today's call is being recorded.
At this time, I would like to turn the conference call over to the Manager of Investor Relations, Anne Crotteau. Please go ahead, Anne.
Thank you, Rachel.